Please click on the links below to access the press releases:
- merit medical Acquires Assets of vascular insights®, LLC– December 17th 2018
- vascular insights® Announces New Chief Executive Officer and President james (chip) draper to Lead the Executive Team- october 30th 2018
- vascular insights® Announces a New Lead To The Global Commercial Team – march 15th 2018
- national institute for Health and Care Excellence (NICE) issues approval via Interventional Procedure Guidance IPG557 for endovenous mechanochemical ablation for varicose veins in the United Kingdom – july 13th 2016
- ClariVein® Workshop Offered in Hong Kong at the Asian Society for Vascular Surgery (ASVS)- September 1st 2014
- vascular insights Announces New VP of Operations – april 7th 2014
- vascular insights Announces Move to Massachusetts – february 4th 2014
- vascular insights Announces Vice President of Marketing – January 6th 2014
- vascular insights Announces New Chief Executive Officer – september 2nd 2013
- professor A H Davies, imperial College London clinical trial comparing ClariVein® with VNUS ClosureFAST– september 2012
- professor C wittens, MD, maastricht university, the netherlands ClariVein® dose finding trial – august 2012
- M reijnen, MD, rijnstate hospital, The Netherlands clinical trial comparing ClariVein® with vnus closurefast – august 2012
- S elias, MD, vascular news – Mechanochemical ablation shows 96% closure rate at two Years– June 2012
- R bernstein, MD, treatment of defiant venous ulcers with ClariVein® – march 2012
